New York, NY, Sept. 19, 2017 -- Registration is now open for YSC Tour de Pink®, a unique and empowering event that challenges cyclists to pedal 200 miles across the state of Florida in the name of young women affected by breast cancer. From April 13 - 15, 2018, participants, including breast cancer survivors, their families and friends, will ride for for one purpose: to ensure no young woman faces breast cancer alone.
|
|||
The event kicks off Friday, April 13 in Tampa and ends Sunday, April 15 near Venice Beach, Florida. Over the weekend, riders will journey 200 miles past the Manatee River, St. Armand’s Circle and through Sarasota.
Tour de Pink is a fundraising event of Young Survival Coalition (YSC), the premier nonprofit dedicated to young women with breast cancer. The funds raised will help educate, empower and connect the more than 12,000 young women who are diagnosed with breast cancer in the U.S. each year.
Though physically challenging, Tour de Pink isn’t just for avid cyclists: it’s a “rolling community” of survivors, partners, family and friends who find support and empowerment in Tour de Pink.
Survivor and rider Tracy D. agrees: “My favorite part of the TdP is the relationships that are formed. There is so much love and support all weekend. It isn't a competition, so everyone supports and encourages everyone.”
Begun in 2004, YSC Tour de Pink® has generated more than $8 million for young women affected by breast cancer. YSC anticipates over 500 riders will participate in this year’s three national events, raising close to $1.5 million.
To learn more about the event, visit: http://south.ysctourdepink.org/
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/af19dcbd-9b82-4e5b-8701-1a5120c21dc1
Emily Helck Young Survival Coalition 6462573024 [email protected]


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Approves Mitapivat for Anemia in Thalassemia Patients
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



